329 related articles for article (PubMed ID: 30395629)
1. Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice.
Potez M; Trappetti V; Bouchet A; Fernandez-Palomo C; Güç E; Kilarski WW; Hlushchuk R; Laissue J; Djonov V
PLoS One; 2018; 13(11):e0206693. PubMed ID: 30395629
[TBL] [Abstract][Full Text] [Related]
2. Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.
Ruddell A; Croft A; Kelly-Spratt K; Furuya M; Kemp CJ
BMC Cancer; 2014 May; 14():354. PubMed ID: 24886322
[TBL] [Abstract][Full Text] [Related]
3. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma.
Bobek V; Kolostova K; Pinterova D; Kacprzak G; Adamiak J; Kolodziej J; Boubelik M; Kubecova M; Hoffman RM
Anticancer Res; 2010 Dec; 30(12):4799-803. PubMed ID: 21187455
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis.
Harrell MI; Iritani BM; Ruddell A
Am J Pathol; 2007 Feb; 170(2):774-86. PubMed ID: 17255343
[TBL] [Abstract][Full Text] [Related]
5. Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice.
Duong T; Proulx ST; Luciani P; Leroux JC; Detmar M; Koopman P; Francois M
Cancer Res; 2012 Jun; 72(12):3105-14. PubMed ID: 22523034
[TBL] [Abstract][Full Text] [Related]
6. Role of thymosin beta4 in tumor metastasis and angiogenesis.
Cha HJ; Jeong MJ; Kleinman HK
J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
[TBL] [Abstract][Full Text] [Related]
7. Role of simvastatin in tumor lymphangiogenesis and lymph node metastasis.
Ji RC; Eshita Y; Kobayashi T; Hidano S; Kamiyama N; Onishi Y
Clin Exp Metastasis; 2018 Dec; 35(8):785-796. PubMed ID: 30255290
[TBL] [Abstract][Full Text] [Related]
8. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous regional lymph node metastases of three variants of the B16 melanoma: relationship to primary tumor size and pulmonary metastases.
Nathanson SD; Haas GP; Mead MJ; Lee M
J Surg Oncol; 1986 Sep; 33(1):41-5. PubMed ID: 3762173
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model.
Culp WD; Neal R; Massey R; Egevad L; Pisa P; Garland D
J Proteome Res; 2006 Jun; 5(6):1332-43. PubMed ID: 16739985
[TBL] [Abstract][Full Text] [Related]
11. Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.
Burghoff S; Gong X; Viethen C; Jacoby C; Flögel U; Bongardt S; Schorr A; Hippe A; Homey B; Schrader J
BMC Cancer; 2014 Dec; 14():898. PubMed ID: 25465225
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
[TBL] [Abstract][Full Text] [Related]
13. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.
Khokha R
J Natl Cancer Inst; 1994 Feb; 86(4):299-304. PubMed ID: 8158685
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.
García-Hernández ML; Hernández-Pando R; Gariglio P; Berumen J
Immunology; 2002 Feb; 105(2):231-43. PubMed ID: 11872099
[TBL] [Abstract][Full Text] [Related]
17. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
18. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages.
Jung JI; Cho HJ; Jung YJ; Kwon SH; Her S; Choi SS; Shin SH; Lee KW; Park JH
Int J Cancer; 2015 Jan; 136(2):258-70. PubMed ID: 24844408
[TBL] [Abstract][Full Text] [Related]
19. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
20. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]